Skip to main content
. 2021 Nov 16;9:770451. doi: 10.3389/fcell.2021.770451

FIGURE 5.

FIGURE 5

Stratification analyses of the signature based on prognosis-related clinicopathological characteristics. The survival outcomes of the patients stratified according to age (A,B), sex (C,D), chromosomal abnormalities (E,F), FLT3 mutations (G,H), IDH1 mutations (I,J), NPM1 mutations (K,L) and RAS mutations (M,N) in the two risk groups.